Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis

ConclusionsOur results suggest that immune tolerance to AHC protein by oral administration is able to provide efficient atheroprotection up to 18  weeks and moderately at later stages. Apart from immune regulatory cells, protective antibodies may also have a role in controlling atherosclerosis.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research